The Ayurvedic Medicine Manufacturers’ Organisation of India (AMMOI) has said that the Union government has begun steps for the registration and licensing of herbal raw materials used in the making of ayurvedic drugs.
Responding to a news report carried by The Hindu (‘Small units’ Ayurvedic drugs may have harmful metals’, October 22), AMMOI general secretary D. Ramanathan clarified on Friday that the units making ‘arishtams’ and ‘asavams’ in the State were cleaning the raw materials regularly irrespective of the size of the company and the quantity of products they were manufacturing.
He pointed out that there were around 650 manufacturing units here and 300 of them were making these drugs. They had Good Manufacturing Practice certificates and were adhering to the Drugs and Cosmetics Act. Drug inspectors were periodically checking their premises to ensure quality. The laboratory set up at CARe Keralam, a resource centre under the Union government, was being used for checking the quality of medicines, Dr. Ramanathan added.
A letter from the Editor
Dear reader,
We have been keeping you up-to-date with information on the developments in India and the world that have a bearing on our health and wellbeing, our lives and livelihoods, during these difficult times. To enable wide dissemination of news that is in public interest, we have increased the number of articles that can be read free, and extended free trial periods. However, we have a request for those who can afford to subscribe: please do. As we fight disinformation and misinformation, and keep apace with the happenings, we need to commit greater resources to news gathering operations. We promise to deliver quality journalism that stays away from vested interest and political propaganda.
Support Quality Journalism
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
